Hypnotic medication: Shed light not heat! [1]

Sleep

Volumn 27, Issue 5, 2004, Pages 1021-

  Kramer, Milton ^a,b  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b Apt PHA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC AGENT;

CHRONIC DISEASE; DRUG INDICATION; HUMAN; INSOMNIA; LETTER; LONG TERM CARE; PRIORITY JOURNAL;

CHRONIC DISEASE; HUMANS; HYPNOTICS AND SEDATIVES; PIPERAZINES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 4143101396     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Jacobs, GD. Is Eszopiclone appropriate and effective for the long-term clinical management of chronic insomnia. Sleep 2004;27:345.
2. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793-9.
3. Buysee DJ. Opening up new avenues for insomnia treatment research. Sleep 2003;26:786-7.
4. Kripke DF. Non nocere if you really care: commentary on "Hypnotic medication in the treatment of chronic insomnia" by Dr. Kramer. Sleep Med Rev 2000;4:543-5.
5. Kramer M. Hypnotic medication in the treatment of chronic insomnia: non nocere! Doesn't anyone care? Sleep Med Rev 2000;4:529-41.
6. Kramer M. Non nocere: but we both care: commentary on "Non nocere if you really care" by Dr Kripke. Sleep Med Rev 2000;4:547-9.